Sofinnova Investments, Inc. Fate Therapeutics Inc Transaction History

Sofinnova Investments, Inc.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$59.27 - $95.73 $2.75 Million - $4.44 Million	-46,386 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$67.25 - $92.52 $565,505 - $778,000	-8,409 Reduced 15.35%	46,386 $4.03 Million
Q1 2021 May 14, 2021	BUY	$72.16 - $117.4 $2.98 Million - $4.85 Million	41,298 Added 305.98%	54,795 $4.52 Million
Q4 2020 Feb 16, 2021	SELL	$38.09 - $100.95 $1.06 Million - $2.82 Million	-27,903 Reduced 67.4%	13,497 $1.23 Million
Q3 2020 Nov 13, 2020	BUY	$30.41 - $40.5 $1.26 Million - $1.68 Million	41,400 New	41,400 $1.65 Million
Q2 2020 Aug 13, 2020	SELL	$20.21 - $35.23 $738,958 - $1.29 Million	-36,564 Closed	0 $0
Q1 2020 May 13, 2020	SELL	$17.28 - $31.88 $10.3 Million - $19.1 Million	-598,579 Reduced 94.24%	36,564 $812,000
Q4 2019 Feb 14, 2020	BUY	$13.39 - $20.73 $3.39 Million - $5.26 Million	253,543 Added 66.44%	635,143 $12.4 Million
Q3 2019 Nov 14, 2019	BUY	$15.47 - $22.5 $5.9 Million - $8.59 Million	381,600 New	381,600 $5.93 Million
Q2 2019 Aug 13, 2019	SELL	$15.61 - $20.44 $3.18 Million - $4.16 Million	-203,742 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$13.15 - $18.71 $342,833 - $487,788	-26,071 Reduced 11.34%	203,742 $3.58 Million
Q4 2018 Feb 14, 2019	BUY	$11.48 - $16.98 $1.43 Million - $2.12 Million	124,922 Added 119.1%	229,813 $2.95 Million
Q3 2018 Nov 15, 2018	BUY	$8.75 - $16.29 $917,796 - $1.71 Million	104,891 New	104,891 $1.71 Million

175

115M

53.7K

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $222M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Sofinnova Investments, Inc. with notifications on news.